Kevin Choe, MD, PhD

Disclosure:
Compensation
Novocure: Honoraria

Presentation(s):

• 95 - Analysis of RTOG-RPA Scores in the Phase 3 EF-14 Trial of Tumor Treating Fields With Temozolomide (TTFields/TMZ) Versus TMZ Alone in Newly Diagnosed Glioblastoma.

  Monday, October 22
  11:15 AM – 11:25 AM